Fused heterocyclic rings as ripk1 inhibitors

The invention provides novel substituted heterocyclic rings represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of RIPK1 and the therape...

Full description

Saved in:
Bibliographic Details
Main Authors KIM Namhee, KIM Sunjoo, MIN Jiae, SEO Jeongbeob, KANG Hongjun, YANG Inho, PARK Kitae, KIM Minha, HAN Cheolkyu, CHOI Sungmin, KWON Youngeun, YOON Cheolhwan, JEONG Heejin, JEON Seeun, HAN Sangbae, KIM Jinyoung
Format Patent
LanguageEnglish
Hebrew
Published 01.05.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides novel substituted heterocyclic rings represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of RIPK1 and the therapeutic methods.
Bibliography:Application Number: IL20240311505